The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.
Abstract
Cannabinoid effects on brain dopaminergic activity vary as a function of gonadal status. In this work, we examined whether these variations might be due to sex steroid-dependent differences in brain cannabinoid receptors (CNr). Four experiments were done: (i) male versus females; (ii) females at each stage of the ovarian cycle; (iii) estradiol (E2) and/or progesterone (P)-replaced ovariectomized (OVX) females; and (iv) testosterone (T)-replaced orchidectomized males. The density of CNr in the medial basal hypothalamus fluctuated in females during the estrous cycle. The density was higher in diestrus and decreased in estrus. This parameter did not change after ovariectomy and E2 replacement. However, P increased the density of CNr when administered to OVX rats acutely treated with E2, but not administered alone or after chronic E2 treatment. In the striatum, the affinity of CNr was slightly higher in males than females, with no changes in density. Ovariectomy increased the affinity of CNr, which normalized only after administration of acute E2. Interestingly, the high affinity values observed in this area after P alone or combined with E2, corresponded to low densities as compared with intact females. In the limbic forebrain, the affinity for the cannabinoid ligand was also higher in males than females with no changes in density. Affinity was also higher in diestrus and lower in estrus, whereas density was unchanged. Ovariectomy decreased CNr density. A normal situation was found after administration of acute E2 or P alone, whereas chronic E2 markedly increased the density of CNr as compared with both intact and OVX females. Interestingly, this latter increase was prevented by coadministration of P. Orchidectomy did not affect CNr density, but administration of T produced a marked decrease. In the mesencephalon, the density and affinity of CNr was higher in males than females. Administration of P to OVX rats produced opposite effects, increasing the density when administered alone and decreasing it when administered to acute E2-replaced OVX rats. In summary, these results reveal the existence of subtle, sometimes more pronounced, sex dimorphisms, fluctuations along the ovarian cycle and changes after gonadectomy and sex steroid replacement in CNr density and affinity in certain brain areas. This supports the hypothesis of possible sex steroid-dependent differences in the sensitivity of certain neuronal processes to cannabinoid treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both studies observed ovarian cyclical changes in cannabinoid receptor density or endocannabinoid content in brain areas potentially associated with nociception, [8,44].”
From Endocannabinoid involvement in endometriosis. (2010) · cites this paper as [44]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I
Glowinski, J., & Iversen, L. L. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb09873.x · Cited by 5,436
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
Howlett, A. C., Qualy, J. M., & Khachatrian, L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 470
Chen, J., Paredes, W. M., Li, J., Smith, D. M., Lowinson, J. H., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253
Research works printed but not linked: 13
- Dill, 1988, J. Pharmacol. Exp. Ther., 244, 1157
- Howlett, 1990, TINS, 13, 420
- Devane, 1988, Mol. Pharmacol., 34, 605
- Herkenham, 1990, 87, 1932
- Howlett, 1986, Mol. Pharmacol., 29, 307
- Dewey, 1986, Pharmacol. Rev., 38, 151
- Howlett, 1988, Mol. Pharmacol., 33, 297
- Pertwee, 1988, Neuropharmacology, 27, 1256
- Bonnin, 1993, Neuroendocrinology
- Gunnet, 1986, 183, 48
- Bridgen, 1990, FASEB J., A996, 4240
- Houston, 1991, Du Pont Biotech Update, 6, 21
- de Fonseca, 1993, Pharmacol. Biochem. Behav.
Cited by
Sorted by citations
Items 201–242 of 242
Navarro, M., & de Fonseca, F. R. (1998) · The Spanish Journal of Psychology · doi:10.1017/s1138741600005394 · Cited by 4
Pees, A., Morrone, C. D., Tong, J., Rong, J., Shao, T., Wear, D., Liang, S. H., Yu, W. H., & Vasdev, N. (2025) · Theranostics · doi:10.7150/thno.106592 · Cited by 3
Gauthier, M., Hebert, L.-P., Dugast, E., Lardeux, V., Letort, K., Thiriet, N., Belnoue, L., Balado, É., Solinas, M., & Belujon, P. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111335 · Cited by 3
Sex-specific responses to cannabis exposure: Implications for behavior and beyond
Rogers, S., Seelke, A. M. H., Mederos, S. L., & Bales, K. L. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111530 · Cited by 3
Rojo, M. L., Söderström, I., & Fowler, C. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.001 · Cited by 3
Forner-Piquer, I., Marzo, V. D., & Carnevali, O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824464-7.00018-0 · Cited by 3
Vered, S., Beiser, A., Sulimani, L., Sznitman, S. R., Gonzales, M. M., Aparicio, H. J., DeCarli, C. S., Scott, M. R., Ghosh, S., Lewitus, G. M., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01301-x · Cited by 3
Endocannabinoids and Dopamine-Related Functions in the CNS
de Miguel, R., Ramos, J. A., Cebeira, M., Hernández, M., & Fernández‐Ruíz, J. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch11 · Cited by 3
Self-citationBanks, P. J., Bennett, P., Sekuler, A. B., & Gruber, A. J. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.884080 · Cited by 2
Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology
Tang, T. Y.-C., Kim, J. S., & Das, A. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.02.003 · Cited by 3
Pereira, C. F., Boileau, I., & Kloiber, S. M. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00155-z · Cited by 3
Atance, J. A. R., & Fernández‐Ruíz, J. (2000) · Adicciones · doi:10.20882/adicciones.672 · Cited by 2
Baacke, K. A., Sullivan, R. M., Shankula, C. A., & Lisdahl, K. M. (2025) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2025.1549771 · Cited by 2
Yadav-Samudrala, B. J., Chapple, B., Thompson, S. A., Wu, Z., Li, Z., Yuan, H., & Fitting, S. (2026) · Cannabis and Cannabinoid Research · doi:10.1177/25785125261450903 · Cited by 1
The Role of Sex and Coping Styles on the Relationship Between Depression and Cannabis Use
Villanueva‐Blasco, V. J., Mateu-Mollá, J., Vázquez‐Martínez, A., Boubeta, A. R., de Fonseca, F. R., & Folgar, M. I. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01275-3 · Cited by 2
Endocannabinoids and Endocrine Function
Murphy, L. L. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch21 · Cited by 1
The endocannabinoid system and female sexual arousal
Klein, C. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0103333 · Cited by 1
Sallam, N. A., Peterson, C., Baglot, S. L., Kohro, Y., Trang, T., Hill, M. N., & Borgland, S. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.540248 · Cited by 1
Amygdala Morphometry in Adolescent Marijuana Users
McQueeny, T. M. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Ovarian hormone modulation of supraspinal THC-Induced analgesia
McBride, A. A. (2013) · Research Exchange (Washington State University)
Endocrinological Effects of Drugs of Abuse
Reed, B., & Kreek, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00087-0
Sex Differences in the Anxiety Effects of Cannabinoids
French, H. T. (2017) · CUNY Academic Works (City University of New York)
ENDOCANNABINOID REGULATION OF ADOLESCENT DEVELOPMENT IN MALE AND FEMALE RATS
Simone, J. J. (2018) · Brock University Digital Repository (Brock University)
Fontaine, C. J. (2018) · UVic’s Research and Learning Repository (University of Victoria)
Ahmed, M. (2020) · TSpace (University of Toronto)
Finn, D. P. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718030800.793480342
Simone, J. J., & McCormick, C. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00008-5
Horkulak, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10060
Sex-dependent effects of stress on insular cortex-to-nucleus accumbens synaptic plasticityPreprint
Gauthier, M., Dugast, E., Lardeux, V., Letort, K., Belnoue, L., Balado, É., Solinas, M., & Belujon, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.28.555067
The Endocannabinoid System and Postnatal Neurodevelopment
Sisk, L. M., Meyer, H. C., Martinez-Garcia, A., & Gee, D. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-87990-6_5
Cannabis use measurement: Identifying the optimal metric for broad research applications
Skrzynski, C. J., Mueller, R. L., Bidwell, L. C., Bryan, A. D., & Hutchison, K. E. (2025) · Addiction · doi:10.1111/add.70205
Reelin in vulnerability and sex-dependent maturational trajectories of the prefrontal cortex
Silva-Hurtado, T. J. (2021) · theses.fr (ABES) · doi:10.70675/ecf0031ez1ac8z4688za735za4cd9acfc52c
Cannabinoid modulation of behavioral processes : from adolescence to adulthood
Ioannidou, C. (2021) · theses.fr (ABES) · doi:10.70675/85fe2023za70dz4d65z83c9z9828ec89522f
Sex and Gender Differences in Cannabis Use Disorder
Mostallino, R., & Fattore, L. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_12
Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
Ku, S.-H., Stringfield, S. J., Torregrossa, M. M., Sweet, R. A., & Chou, S. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250886
Raymundi, A. M., Cardoso, N. C., Lourenço, G. C., Queiroz, R., Dolzan, M. D., Vitali, L., Meyer, E., Lisboa, S. F. D. S., Guimarães, F. S., Pinna, G., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02434-x
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Gaulden, A. D., Chase, K., & McReynolds, J. R. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111139
Metadata
- Authors
- de Fonseca, F. R., Cebeira, M., Ramos, J. A., Martín, M., & Fernández-Ruiz, J. J.
- Affiliations
- Universidad Complutense de Madrid (ES)
- ORCID
- Martín, M.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 1994-01
- Volume
- 54
- Issue
- 3
- Pages
- 159-170
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2056795643
- Cited by
- 243
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 18 · 2022: 12 · 2021: 18 · 2020: 14 · 2019: 4 · 2018: 10 · 2017: 12 · 2016: 8 · 2015: 11 · 2014: 9 · 2013: 9 · 2012: 9
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- cannabinoid receptors, sex differences, estrous cycle, gonadectomy, estradiol, progesterone, testosterone, ovariectomy, orchiectomy, receptor density, receptor binding affinity, medial basal hypothalamus, striatum, limbic forebrain, midbrain, dopaminergic activity, gonadal status
- MeSH terms
- Animals, Brain, Cannabinoids, Cyclohexanols, Dopamine, Estradiol, Estrus, Female, Kinetics, Male, Neurons, Orchiectomy, Ovariectomy, Ovary, Progesterone, Receptors, Drug, Sex Characteristics, Testis, Testosterone, Dronabinol, Tritium, Rats, Wistar, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review